FDA Approves Guardant Health's Colon Cancer Screening Blood Test
The FDA just approved Guardant Health's blood test, Shield, to screen for colon cancer. While it won't replace colonoscopies, it's generating excitement among doctors.
Supply Chain Vulnerabilities Exposed by Shortages of Cancer Drugs
Shortages of chemotherapy drugs, such as cisplatin and carboplatin, are leading to calls for strengthening the U.S. drug supply chain.